A new company offering glycaemic index (GI) and novel food testing in human volunteers has been spun off from NHS nutrition and dietetic research at Hammersmith Hospital in London.


Hammersmith Food Research said it plans to offer companies throughout the food chain measurement and advice, as industry interest in GI measurement increases.


“The link between low GI diets and reduced risk of diseases such as diabetes and heart disease is strengthening,” said Dr Gary Frost, head of nutrition and dietetics at Hammersmith Hospitals NHS Trust and a director of the new company.


“This may be responsible for an increasing interest in GI from the food industry. Hammersmith Food Research can put into practice over ten years of research, making that expertise available and accessible. We also offer the backing an important research hospital confers in terms of infrastructure and access to human volunteers,” Frost added.


GI testing involves measuring the effect different foods have on blood sugar in comparison with pure glucose. Foods with a lower GI cause smaller peaks in blood sugar levels over time. It is this that is believed to offer better protection against diabetes and other diseases compared with higher GI diets.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.